These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35174853)

  • 21. The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model.
    Machado I; Mayordomo-Aranda E; Giner F; Llombart-Bosch A
    Fetal Pediatr Pathol; 2015; 34(5):271-81. PubMed ID: 26125949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.
    Morotti RA; Nicol KK; Parham DM; Teot LA; Moore J; Hayes J; Meyer W; Qualman SJ;
    Am J Surg Pathol; 2006 Aug; 30(8):962-8. PubMed ID: 16861966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
    Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
    Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma.
    Cui S; Hano H; Harada T; Takai S; Masui F; Ushigome S
    Pathol Int; 1999 Jan; 49(1):62-8. PubMed ID: 10227726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside.
    Martynov I; Dhaka L; Wilke B; Hoyer P; Vahdad MR; Seitz G
    Front Oncol; 2024; 14():1333129. PubMed ID: 38371622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model.
    Dobson CC; Naing T; Beug ST; Faye MD; Chabot J; St-Jean M; Walker DE; LaCasse EC; Stojdl DF; Korneluk RG; Holcik M
    Oncotarget; 2017 Jan; 8(2):3495-3508. PubMed ID: 27966453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiling the molecular difference between Patched- and p53-dependent rhabdomyosarcoma.
    Kappler R; Bauer R; Calzada-Wack J; Rosemann M; Hemmerlein B; Hahn H
    Oncogene; 2004 Nov; 23(54):8785-95. PubMed ID: 15480423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
    He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
    Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
    Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response.
    Kang Z; Chen JJ; Yu Y; Li B; Sun SY; Zhang B; Cao L
    Clin Cancer Res; 2011 May; 17(10):3181-92. PubMed ID: 21385927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
    Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
    Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of DNA methylation to mutational changes and transcriptional organization in fusion-positive and fusion-negative rhabdomyosarcoma.
    Sun W; Chatterjee B; Shern JF; Patidar R; Song Y; Wang Y; Walker RL; Pawel BR; Linardic CM; Houghton P; Hewitt SM; Edelman DC; Khan J; Meltzer PS; Barr FG
    Int J Cancer; 2019 Jun; 144(11):2707-2717. PubMed ID: 30565669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile].
    Botiralieva GK; Sharlai AS; Roshchin VY; Sidorov IV; Konovalov DM
    Arkh Patol; 2020; 82(5):33-41. PubMed ID: 33054030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma.
    Jo VY; Mariño-Enríquez A; Fletcher CD
    Am J Surg Pathol; 2011 Oct; 35(10):1523-30. PubMed ID: 21921782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience.
    Pondrom M; Bougeard G; Karanian M; Bonneau-Lagacherie J; Boulanger C; Boutroux H; Briandet C; Chevreau C; Corradini N; Coze C; Defachelles AS; Galmiche-Roland L; Orbach D; Piguet C; Scoazec JY; Vérité C; Willems M; Frebourg T; Minard V; Brugières L
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28486. PubMed ID: 32658383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative splicing of MEF2C pre-mRNA controls its activity in normal myogenesis and promotes tumorigenicity in rhabdomyosarcoma cells.
    Zhang M; Zhu B; Davie J
    J Biol Chem; 2015 Jan; 290(1):310-24. PubMed ID: 25404735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
    Mentzel T; Kuhnen C
    Virchows Arch; 2006 Nov; 449(5):554-60. PubMed ID: 17013628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice.
    Seitz G; Pfeiffer M; Fuchs J; Warmann SW; Leuschner I; Vokuhl C; Lang P; Handgretinger R; Armeanu-Ebinger S
    Oncol Rep; 2010 Oct; 24(4):1067-72. PubMed ID: 20811690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
    Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
    PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.